Germany

A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

Hsinchu, Taiwan and Florence, Italy, July 24th, 2020

ralesci Congresses with "Zero Impact®" on the environmentive drug for chronic hyperuricaemia in gout.D VitaPCR® POC instrument.

On August 20th the German Minister of Health, Jens Spahn visited the Red Cross Hospital of Mölln-Ratzeburg. 

Menarini Diagnostics acquires EOS Preanalytics and Point Of Care company assets

FLORENCE, January 15th, 2021 - Menarini Diagnostics, a company of the Menarini Group

COVID-19: MENARINI, NEW MADE IN ITALY REAGENT TO ISOLATE VIRAL RNA

Menarini Diagnostics, a company of the Menarini Group, launches the Leasy Kit.
123

Our values

4 values, which have given life to Menarini and shaped its history

READ MORE »